top of page

VAXIGRIPTETRA SUSPENSION FOR INJECTION IN PREFILLED SYRINGE

Product details

Registration number: SIN15477P

Classification: Prescription Only

Active ingredients:

  • INFLUENZA VIRUS (NH) A/Croatia/10136RV/2023(H3N2) - like strain (A/Croatia/10136RV/2023, X-425A)
  • INFLUENZA VIRUS (NH) A/Victoria/4897/2022 (H1N1)pdm09-like strain (A/Victoria/4897/2022, IVR-238)
  • INFLUENZA VIRUS (NH) B/Austria/1359417/2021 - like strain (B/Michigan/01/2021, wild type)
  • INFLUENZA VIRUS (NH) B/Phuket/3073/2013 - like strain (B/Phuket/3073/2013, wild type)

Strength:

  • 15 mcg/0.5 ml
  • 15 mcg/0.5 ml
  • 15 mcg/0.5 ml
  • 15 mcg/0.5 ml

Dosage form: INJECTION, SUSPENSION

Route: SUBCUTANEOUS; INTRAMUSCULAR

Registrant: SANOFI-AVENTIS SINGAPORE PTE. LTD.

ATC code: J07BB02

HSA approval date: 4 May 2018

Manufacturer(s):

  • SANOFI WINTHROP INDUSTRIE - LE TRAIT (Primary and secondary packager)
  • SANOFI PASTEUR – VAL DE REUIL (VDR)

Manufacturing country/countries: FRANCE

What are the HSA registration number and classification for VAXIGRIPTETRA SUSPENSION FOR INJECTION IN PREFILLED SYRINGE?

According to the HSA dataset updated 7 August 2026:

Registration number: SIN15477P

Classification: Prescription Only

Source for this answer

What active ingredients and strength are recorded for VAXIGRIPTETRA SUSPENSION FOR INJECTION IN PREFILLED SYRINGE?

According to the HSA dataset updated 7 August 2026:

Active ingredients:

  • INFLUENZA VIRUS (NH) A/Croatia/10136RV/2023(H3N2) - like strain (A/Croatia/10136RV/2023, X-425A)
  • INFLUENZA VIRUS (NH) A/Victoria/4897/2022 (H1N1)pdm09-like strain (A/Victoria/4897/2022, IVR-238)
  • INFLUENZA VIRUS (NH) B/Austria/1359417/2021 - like strain (B/Michigan/01/2021, wild type)
  • INFLUENZA VIRUS (NH) B/Phuket/3073/2013 - like strain (B/Phuket/3073/2013, wild type)

Strength:

  • 15 mcg/0.5 ml
  • 15 mcg/0.5 ml
  • 15 mcg/0.5 ml
  • 15 mcg/0.5 ml

Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.

Source for this answer

What dosage form and route are recorded for VAXIGRIPTETRA SUSPENSION FOR INJECTION IN PREFILLED SYRINGE?

According to the HSA dataset updated 7 August 2026:

Dosage form: INJECTION, SUSPENSION

Route: SUBCUTANEOUS; INTRAMUSCULAR

Source for this answer

Who is the recorded registrant for VAXIGRIPTETRA SUSPENSION FOR INJECTION IN PREFILLED SYRINGE?

According to the HSA dataset updated 7 August 2026:

Registrant: SANOFI-AVENTIS SINGAPORE PTE. LTD.

Source for this answer

Which manufacturers and countries are listed for VAXIGRIPTETRA SUSPENSION FOR INJECTION IN PREFILLED SYRINGE?

According to the HSA dataset updated 7 August 2026:

Manufacturer(s):

  • SANOFI WINTHROP INDUSTRIE - LE TRAIT (Primary and secondary packager)
  • SANOFI PASTEUR – VAL DE REUIL (VDR)

Manufacturing country/countries: FRANCE

Source for this answer

Where can I look up VAXIGRIPTETRA SUSPENSION FOR INJECTION IN PREFILLED SYRINGE in the HSA register?

Open HSA’s therapeutic product register and search for registration number SIN15477P or the exact product name VAXIGRIPTETRA SUSPENSION FOR INJECTION IN PREFILLED SYRINGE. The general register link does not preselect this product.

Source for this answer

What are the source dates for this VAXIGRIPTETRA SUSPENSION FOR INJECTION IN PREFILLED SYRINGE record?

This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.

The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.

Source for this answer

Has this VAXIGRIPTETRA SUSPENSION FOR INJECTION IN PREFILLED SYRINGE record had a separate HSA register check?

No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.

Search the HSA register using SIN15477P for the latest record.

Source for this answer

Sources and dates

HSA dataset: 2026. Updated: 13 November 2026.

Factual product information only; no dosing, treatment or suitability advice.

Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.

bottom of page